Comparison of Research Compounds and Liver Impact
To put this all in context, let's compare MK-677 to other types of compounds used in research. Seeing them side-by-side makes the distinctions incredibly clear. Compound Class Ghrelin Receptor Agonist Anabolic-Androgenic Steroid Synthetic Peptide Administratio
This comparison does not assign a generated winner or score.
- To put this all in context, let's compare MK-677 to other types of compounds used in research. Seeing them side-by-side makes the distinctions incredibly clear.
- Compound Class
- Ghrelin Receptor Agonist
- Anabolic-Androgenic Steroid
- Synthetic Peptide
- Administration
- Oral
- Injectable / Oral (Capsules)
- Primary Mechanism
- Stimulates endogenous GH/IGF-1
- Binds to Androgen Receptors
- Promotes Angiogenesis/Repair
- Direct Liver Pathway
- Not directly hepatotoxic
- 17-alpha-alkylated; high stress
- Generally considered non-toxic
- Typical Impact on ALT/AST
- Generally none to minimal
- Significant, often dramatic elevation
- None reported in studies
- Primary Concern
- Insulin resistance, water retention
- Direct, acute hepatotoxicity
- Systemic effects still under study
- This table illustrates the point perfectly. The type of risk associated with MK-677 is metabolic, not directly toxicological in the way an oral steroid's is. This dictates an entirely different approach to safety monitoring.